Compared with normal samples, EXO1, RMI2, and RAD51 were significantly overexpressed in most cancer types including BRCA, while RMI2 was significantly lower expressed in PARD (Prostate adenocarcinoma; Supplementary Figure 2). Here, RAD51 is linked to prostate adenocarcinoma.